Introduction: Herein we provide clinical, biochemical, histological and radiological evidence of a rare case of a male patient who was diagnosed with pituitary macroadenoma (prolactinoma), phaeochromocytoma and a lung typical-carcinoid tumour on a background of SDH gene mutation encoding the succinate dehydrogenase enzyme.
Presentation of case: A 42 year old male individual, was initially diagnosed with a pituitary macroadenoma (prolactinoma) after complaining of persisting severe headaches, for which cabergoline treatment had been initiated.
His positive paternal history of phaeochromocytoma, led to further genetic screening which revealed a c.600>A, p.(Trp200*) mutation in the SDHB gene and further biochemical and imaging studies confirmed the presence of a phaeochromocytoma, which was surgically excised.
Following a random hospital visit, a plain chest radiograph raised concerns over a right lower lobe mass which ultimately led to advanced imaging studies with CT and PET, confirming the presence of a neoplastic lesion with no evidence of lymphadenopathy of other evidence of metastatic disease.
A subsequent lobectomy and Histopathological analysis (positive for chromogranin and synaptophysin) confirmed the diagnosis of a typical carcinoid tumour (stage pT1b N0 Mx).
Discussion: The role of mutations in the genes encoding the succinate dehydrogenase (SDH) subunits, in tumorigenesis has been described previously and especially the predisposition to the development of the hereditary paraganglioma/phaeochromocytoma syndrome (HPGL/PCC).
To our knowledge this may be the first reported case of a lung neuroendocrine tumour, phaeochromocytoma and pituitary macroadenoma on the background of a mutation in the SDHB gene.